Clinical Trial Update: Permeability Enhancement to Reduce Chronic Inflammation [NA]

View source ↗

Summary

A completed clinical trial investigating permeability enhancement to reduce chronic inflammation in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Inflammation

Snippet

Sponsor: Vantive Health LLC | Conditions: End Stage Renal Disease, Inflammation | NA | Status: COMPLETED